News and Events
Dr. Chang's ECG device designed for long QT syndrome screening in newborns recently entered phase two of development. He has described his ECG device as his "big one," the one he believes can potentially save the most lives.
"There are about 2,000 occurrences of SIDS per year. I don't think the monitor will prevent all SIDS, but I think it can have the potential to save several hundred lives if it is really effective and finally brought to the market," Dr. Chang said. "We have to prove it in a clinical trial."
Dr. Charles Grob, Division Chief of Child and Adolescent Psychiatry at Harbor-UCLA, is the recipient of $200,000 for his study on the effects of psilocybin treatment in cancer patients from the Kenneth T. & Eileen L. Norris Foundation.
Dr. Grob was the first investigator in 40 years to use psilocybin to treat cancer anxiety. Psilocybin, the key compound in so-called "magic mushrooms," was used in his pilot study of 12 patients to treat the anxiety and depression of terminally ill cancer patients. His studies have played a key role in the resurgence of research into psychedelic drugs as a means of treatment and therapy.
The Norris Foundation has been a longtime supporter of LA BioMed, Harlyne J. Norris having received LA BioMed's Spirit of Excellence Award for Inspirational Leadership.
Halloween is nearly upon us and Harbor Pediatrics has a few events to celebrate the spooky occasion. ">Last year's Halloween festivities were great with CoachArt activities such as music and face painting going on in the playroom and trick-or-treating with pediatric patients in the wards. This year, both are back and now there is a costume contest to go along with the Halloween party.
- Thursday, October 30th, Child Life Services will be hosting CoachArt in the Child Life Clinic Playroom. Activities will take place from 1pm to 4pm. Halloween with CoachArt last year was great and this one should be as well.
- Friday, October 31st, there will be trick-or-treating in the 6E Ward of Pediatrics from 10am to noon.
Children's Health Research Program, an initiative created by Drs. Lynne Smith and Patricia Dickson, is hosting an open house and ice cream social for pediatrics faculty to highlight and showcase their research interests.
When: Wednesday, October 29th, 2014 @ 3:30pm
Where: CDCRC Conference Room
All LABIOMED employees are encouraged to attend as well.
See the Flier
A three paragraph news wire-style blurb in the Daily Breeze succinctly shares the details: A girl fell from a cliff in Rancho Palos Verdes, was airlifted to a nearby hospital, and received care. The article ends abruptly, but it doesn’t tell the whole story. The mother of that girl followed up with an impassioned op-ed fleshing out the details of her horrible day, and the hospital, Harbor-UCLA Medical Center, that made that day better. The last sentence of that blurb reads: "The girl was airlifted to County Harbor-UCLA Medical Center for treatment." For the mother, Ms. Barbara Menzelos, that made all the difference in the world.
On July 25th, the ground crumbled under Barbara Menzelos' daughter, causing her to lose her balance and fall of the cliff.
She says she received the call while cutting up fruit with my cousin for my son's 10th birthday party. Her could barely get the words out of her mouth told her to go to Malaga Cove immediately. From the hysterics in her friend's voice, she knew it wasn't good news. Barbara's daughter was airlifted via helicopter to Harbor-UCLA.
Assistant Professor of Pediatrics and faculty member of Medical Genetics Tsui-Fen Chou, Ph.D., is credited for her role in the early stage development of molecule CB-5083 which will be a lead drug candidate in patients with relapsed and refractory multiple myeloma. Phase 1 clinical testing has already begun.
CB-5083 came out of DBeQ and ML240, which Dr. Chou developed in collaboration with the NIH MLPCN program when she was a postdoctoral fellow. Cleave Biosciences took her ML240 scaffold, made a few chemical modifications to it, to enhance potency and reduce metabolism, to generate CB-5083.
In a press release from Cleave Biosciences, Dr. Chou is credited as a discovery partner of CB-5083.
Raymond Deshaies, PhD, founder of Cleave Biosciences, credits Dr. Chou and her involvement with the creation of CB-5083. "It's a remarkable achievement that work that Dr. Chou spearheaded has led, in a fairly direct fashion, to a human clinical trial."
Celebrities from movies, sports, and even magic surprised our patients (and staff) with a visit on September 16th for an amazing day of fun and tons of laughs thanks to Stars 4 Smiles, an organization dedicated to bringing smiles to the faces of hospitalized children across Southern California.
Rita Tateel, President of The Celebrity Source and founder of Stars 4 Smiles, says she was inspired to create the organization because as a child, she was hospitalized from age 3 to 5. The hospitalization traumatized her so much that she stopped talking for a year. "The idea of being able to bring smiles to hospitalized children and their families felt like the perfect way to give back to the community," says Rita.
Harbor-UCLA patient and mother Maria Cervantes is expecting quadruplets. She and her husband Rodrigo Cervantes have not had an easy road but since they came to Harbor-UCLA, they've received excellent care and are excited about the incoming additions to their family.
It wasn't until four months into her pregnancy during a visit at her previous hospital that Mrs. Cervantes found out that she was pregnant with not one baby, but four. The surprise came when Mrs. Cervantes was feeling sick during her pregnancy, and what was supposed to be a routine ultrasound revealed four babies and not just one.
"Doctors and nurses were coming in and out. They wouldn't show me the monitor. I said 'If something is wrong, I want you to please tell my husband to come in. I want him here before you tell me something is wrong.'" After Mr. Cervantes entered the room, the doctor asked the married couple of 17 years "how many children do you want?" In disbelief and not quite getting the hint, Mrs. Cervantes saw the doctor type Quad A into his computer and her suspicions arose.
We caught up with the Dr. Tom Kallay & the Simulation Center recently for the Summer Newsletter. His research interests include medical education with an emphasis on simulation-based techniques, and currently is the Director of the Simulation and Skills Center at Harbor-UCLA. Since joining the faculty in 2006, he has received two Outstanding Faculty Teaching Awards from the Department of Pediatrics Residency Program.
The Sim Center has come a long way since 2011, when it was only beginning in earnest. Many of the programs and features that are present today existed only in the minds of Dr. Tom Kallay, Director of Simulation and Skills Center at Harbor-UCLA and his indispensable Simulation Coordinator Johnny DiBonaventura.
In 2011, there was no control room, no high definition televisions, and no video recording. There was, however, blue Cold War-era carpet -- a furry reminder that the space in which the Sim Center currently occupies was once a part of modest military barracks.